Class I antibody induction by rat endothelium.

Area of Science:

• Immunology
• Transplantation Biology
• Vascular Surgery

Background:

• Allogeneic transplantation of vascular grafts can elicit immune responses in recipients.
• The specific cellular components responsible for initiating these immune responses, particularly antibody production, require elucidation.

Purpose of the Study:

• To investigate the necessity of vascular endothelium and circulating passenger leukocytes in inducing antibody responses following allogeneic vein graft transplantation.
• To determine the role of donor endothelium in the generation of recipient antibodies.

Main Methods:

• Transplantation of supradiaphragmatic vein grafts between different rat strains (ACI to Fisher).
• Graft preparation with and without endothelium (using collagenase or scraping).
• Assessment of recipient antibody production (lymphocytotoxic, hemagglutinating, IgG) via serological assays and indirect immunofluorescence.
• Antibody characterization through absorption studies with donor red blood cells.

Main Results:

• Vein grafts from immunosuppressed and irradiated donors induced lymphocytotoxic and hemagglutinating antibodies in recipients.
• IgG antibodies in recipients were identified as donor-specific by indirect immunofluorescence.
• Removal of endothelium from donor veins abrogated antibody induction.
• Antibodies were specifically absorbed by donor red blood cells, confirming donor specificity.

Conclusions:

• The vascular endothelium of allogeneic vein grafts is essential for inducing a humoral immune response, specifically antibody production.
• Circulating passenger leukocytes do not appear to be the primary drivers of this antibody response.
• Endothelial cells are capable of inducing Class I antibodies during allogeneic transplantation.